Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Publication Date Apr 2012
Publisher GlobalData
Product Type Report
Pages 64
Single User License $ 3995.00
Site User License $ 7990.00
Corporate User License $ 11985.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Clostridium difficile (CDI) Therapeutics market. The report identifies the key trends shaping and driving the global Clostridium difficile (CDI) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Clostridium difficile (CDI) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Clostridium difficile (CDI) Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Clostridium difficile (CDI) Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Clostridium difficile (CDID) Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Clostridium difficile (CDI) Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Clostridium difficile (CDI) Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Clostridium difficile (CDI) Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Clostridium difficile (CDI) Therapeutics market landscape? – Identify, understand and capitalize.


Companies Mentioned

Merck & Co., Inc Sanofi Cubist Pharmaceuticals, Inc. Novartis AG. ViroPharma Incorporated Actelion Ltd.

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 CDI Therapeutics - Introduction 7
2.1 Overview 7
2.2 Pathophysiology 7
2.3 Epidemiology 7
2.4 Etiology 8
2.5 Symptoms 8
2.6 Diagnosis 9
2.7 Treatment and Management Pattern 9
2.8 GlobalData Report Guidance 10
3 CDI Therapeutics - Market Characterization 11
3.1 CDI Therapeutics Global Market Size (2006-2011) 11
3.2 CDI Therapeutics Global Market Forecast (2011-2019) 12
3.3 CDI Therapeutics Market (2006-2011) - The US 13
3.4 CDI Therapeutics Market Forecast (2011-2019) - The US 14
3.5 CDI Therapeutics Market (2006-2011) - France 15
3.6 CDI Therapeutics Market Forecast (2011-2019) - France 16
3.7 CDI Therapeutics Market (2006-2011) - Germany 17
3.8 CDI Therapeutics Market Forecast (2011-2019) - Germany 18
3.9 CDI Therapeutics Market (2006-2011) - Spain 19
3.10 CDI Therapeutics Market Forecast (2011-2019) - Spain 20
3.11 CDI Therapeutics Market (2006-2011) - Italy 21
3.12 CDI Therapeutics Market Forecast (2011-2019) - Italy 22
3.13 CDI Therapeutics Market (2006-2011) - The UK 23
3.14 CDI Therapeutics Market Forecast (2011-2019) - The UK 24
3.15 CDI Therapeutics Market (2006-2011) - Japan 25
3.16 CDI Therapeutics Market Forecast (2011-2019) - Japan 26
3.17 Drivers and Barriers for the CDI Therapeutics Market 27
3.17.1 CDI Therapeutics Market Drivers 27
3.17.2 CDI Therapeutics Market Barriers 28
3.18 Opportunity and Unmet Need 28
3.19 Key Takeaway 29
4 CDI Therapeutics - Competitive Assessment 30
4.1 Overview 30
4.2 Strategic Competitor Assessment 30
4.3 Product Profiles of the Major Market Products in the CDI Therapeutics Market 31
4.3.1 Vancocin (Vancomycin Hydrochloride Capsules) 31
4.3.2 Metronidazole 33
4.3.3 Dificid (fidaxomicin) 33
4.4 CDI Therapeutics - Major Marketed Products Comparison 34
4.5 Key Takeaway 34
5 CDI Therapeutics - Pipeline Assessment 35
5.1 Overview 35
5.2 Strategic Pipeline Assessment 35
5.3 CDI Therapeutics Market - Pipeline Assessment by Phase of Development 35
5.3.1 CDI Therapeutics market - Phase III Pipeline 35
5.3.2 CDI Therapeutics Market - Phase II Pipeline 36
5.3.3 CDI Therapeutics Market - Phase I Clinical Pipeline 36
5.3.4 CDI Therapeutics Market - Preclinical Pipeline 36
5.4 CDI Therapeutics - Pipeline by Mechanism of Action 37
5.5 Technology Trends Analytical Framework 38
5.6 CDI Therapeutics Market - Most Promising Drugs under Clinical Development 39
5.7 Most Promising Drug Profiles 39
5.7.1 MK-3415A 39
5.8 Key Takeaway 40
6 CDI Therapeutics - Clinical Trials Mapping 41
6.1 Clinical Trials by Region/Country (US, EU-5 and Japan) 41
6.2 Clinical Trials by Phase of Clinical Development 42
6.3 Clinical Trials by Trial Status 43
6.4 Prominent Sponsors 44
6.4.1 Brief Profiles of Top 10 Companies Participating in Therapeutics Clinical Trials 45
7 CDI Therapeutics - Strategic Assessment 46
7.1 Key Events Impacting the Future Market 46
7.2 Future Market Competition Scenario 47
8 CDI Therapeutics - Future Players 48
8.1 Introduction 48
8.2 Company Profiles 48
8.2.1 Merck & Co., Inc 48
8.2.2 Sanofi 50
8.2.3 Cubist Pharmaceuticals, Inc. 52
8.2.4 Novartis AG. 53
8.2.5 ViroPharma Incorporated 55
8.2.6 Actelion Ltd. 56
8.2.7 Key Takeaway 57
9 CDI Therapeutics - Licensing & Partnership Deals 58
10 CDI therapeutics - Appendix 59
10.1 Market Definitions 59
10.2 Acronyms 59
10.3 Methodology 60
10.3.1 Coverage 60
10.3.2 Secondary Research 60
10.3.3 Forecasting 61
10.3.4 Primary Research 63
10.3.5 Expert Panel Validation 63
10.4 Contact Us 63
10.5 Disclaimer 63
10.6 Bibliography 64

List of Tables
1.1 List of Tables
Table 1: CDI Therapeutics Market, Global, Revenue ($m), 2006-2011 11
Table 2: CDI Therapeutics, Major Market, Global, Forecast ($m), 2011-2019 12
Table 3: CDI Therapeutics Market, The US, Revenue ($m), 2006-2011 13
Table 4: CDI Therapeutics, Major Market, the US, Forecast ($m), 2011-2019 14
Table 5: CDI Therapeutics, France, Revenue ($m), 2006-2011 15
Table 6: CDI Therapeutics Market, France, Forecast ($m), 2011-2019 16
Table 7: CDI Therapeutics, Germany, Revenue ($m), 2006-2011 17
Table 8: CDI Therapeutics Market, Germany, Forecast ($m), 2011-2019 18
Table 9: CDI Therapeutics, Spain, Revenue ($m), 2006-2011 19
Table 10: CDI Therapeutics Market, Spain, Forecast ($m), 2011-2019 20
Table 11: CDI Therapeutics, Italy, Revenue ($m), 2006-2011 21
Table 12: CDI Therapeutics Market, Italy, Forecast ($m), 2011-2019 22
Table 13: CDI Therapeutics, The UK, Revenue ($m), 2006-2011 23
Table 14: CDI Therapeutics, Major Market, The UK, Forecast ($m), 2011-2019 24
Table 15: CDI Therapeutics, Japan, Revenue ($m), 2006-2011 25
Table 16: CDI Therapeutics, Major Market, Global, Forecast ($m), 2011-2019 26
Table 17: Major Marketed Products Comparison in CDI Therapeutics Market, 2011 34
Table 18: CDI Therapeutics - Phase III Pipeline, 2011 35
Table 19: CDI Therapeutics - Phase II Pipeline, 2011 36
Table 20: CDI Therapeutics - Phase I Pipeline, 2011 36
Table 21: CDI Therapeutics - Preclinical Pipeline, 2011 36
Table 22: CDI Therapeutics Market - Most Promising Drugs Under Clinical Development, 2011 39
Table 23: CDI Therapeutics - Clinical Trials by Country, 2011 41
Table 24: CDI Therapeutics, Major Markets - Clinical Trials by Phase, 2011 42
Table 25: CDI Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 43
Table 26: CDI Therapeutics, Major Markets, Prominent Sponsors, 2011 44
Table 27: CDI Therapeutics Market, Global, Clinical Trials by Lead Sponsors, 2011 45
Table 28: Merck Pipeline Products, 2011 50
Table 29: Sanofi Pipeline Products 2011 52
Table 30: Forest Pipeline Products 2011 53
Table 31: Novartis Pipeline Product 2011 55
Table 32: ViroPharma Pipeline Products 2011 56
Table 33: Actelion Pipeline Products 2011 57
Table 34: Licensing and Partnership Deals 58

List of Figures
1.2 List of Figures
Figure 1: Treatment and Management Pattern for CDI 9
Figure 2: CDI Therapeutics Market, Global, Revenue ($m), 2006-2011 11
Figure 3: CDI Therapeutics Market, Global, Forecast ($m), 2011-2019 12
Figure 4: CDI Therapeutics Market, The US, Revenue ($m), 2006-2011 13
Figure 5: CDI Therapeutics Market, The US, Forecast ($m), 2011-2019 14
Figure 6: CDI Therapeutics Market, France, Revenue ($m), 2006-2011 15
Figure 7: CDI Therapeutics Market, France, Forecast ($m), 2011-2019 16
Figure 8: CDI Therapeutics Market, Germany, Revenue ($m), 2006-2011 17
Figure 9: CDI Therapeutics Market, Germany, Forecast ($m), 2011-2019 18
Figure 10: CDI Therapeutics Market, Spain, Revenue ($m), 2006-2011 19
Figure 11: CDI Therapeutics Market, Spain, Forecast ($m), 2011-2019 20
Figure 12: CDI Therapeutics Market, Italy, Revenue ($m), 2006-2011 21
Figure 13: CDI Therapeutics Market, Italy, Forecast ($m), 2011-2019 22
Figure 14: CDI Therapeutics Market, The UK, Revenue ($m), 2006-2011 23
Figure 15: CDI Therapeutics Market, The UK, Forecast ($m), 2011-2019 24
Figure 16: CDI Therapeutics Market, Japan, Revenue ($m), 2006-2011 25
Figure 17: CDI Therapeutics Market, Japan, Forecast ($m), 2011-2019 26
Figure 18: Opportunity and Unmet Need in the CDI Therapeutics Market 29
Figure 19: Strategic Competitor Assessment, 2011 31
Figure 20: CDI Therapeutics - Clinical Pipeline by Mechanism of Action, 2011 37
Figure 21: CDI Therapeutics Market - Pipeline by Phase of Development, 2011 37
Figure 22: Technology Trends Analytics Framework, 2011 38
Figure 23: Technology Trends Analytics Framework - Description, 2011 38
Figure 24: CDI Therapeutics - Clinical Trials by Country, 2011 41
Figure 25: CDI Therapeutics, Major Markets - Clinical Trials by Phase, 2011 42
Figure 26: CDI Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 43
Figure 27: CDI Therapeutics, Major Markets, Prominent Sponsors, 2011 44
Figure 28: CDI Therapeutics, Major Markets, Clinical Trials of Top Ten Companies by Phase, 2011 45
Figure 29: CDI Therapeutics Market, Drivers and Barriers, 2011 46
Figure 30: Implications for Future Market Competition in the CDI Therapeutics Market, 2011 47
Figure 31: CDI Therapeutics Market - Clinical Pipeline by Company, 2011 48
Figure 32: GlobalData Market Forecasting Model 62

Title Date Price
By Netscribes (India) Pvt. Ltd.
May 2012 $0.00
Medical Devices Market in Russia 2009-2013
By Infiniti Research Ltd
Medical devices comprise surgical equipment & appliances, diagnostic devices, X-ray, ophthalmic equipment, laboratory devices & diagnostics, dental equipment, medical disposables and others.The Russia ...Read More
Mar 2010 $1500.00
2010 Perfect Vision GmbH - Medical Equipment - Deals and Alliances Profile
By GlobalData
2010 Perfect Vision GmbH - Medical Equipment - Deals and Alliances ProfileSummary20/10 Perfect Vision AG is engaged in the development, manufacturing and marketing of innovative technologies for raisi ...Read More
Jan 2012 $250.00
2010 U.S. Ambulatory Surgical & Emergency Centers Industry Report
By Barnes Reports
The U.S Ambulatory Surgical & Emergency Centers Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features ...Read More
Jan 2010 $149.00
2010 U.S. Biological Product Manufacturing Industry Report
By Barnes Reports
The U.S. Biological Product Manufacturing Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 ...Read More
Jan 2010 $149.00
2010 U.S. HMO Medical Centers Industry Report
By Barnes Reports
The U.S HMO Medical Centers Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and 20 ...Read More
Jan 2010 $149.00
2010 U.S. Home Health Care Services Industry Report
By Barnes Reports
The Home Health Care Services Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and ...Read More
Oct 2009 $149.00
2010 U.S. Kidney Dialysis Centers Industry Report
By Barnes Reports
The U.S Kidney Dialysis Centers Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current an ...Read More
Jan 2010 $149.00
2010 U.S. Medical & Surgical Hospitals Industry Report
By Barnes Reports
The Medical & Surgical Hospitals Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current a ...Read More
Oct 2009 $149.00
2010 U.S. Medical Laboratories Industry Report
By Barnes Reports
The Medical Laboratories Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and 2011 ...Read More
Oct 2009 $149.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z